As the global landscape for antibody drug development enters an exciting new era, innovations in Antibody Drug Conjugates (ADCs) and bispecific antibodies are driving the industry toward unprecedented growth. The continuous expansion of the market, especially in China, is making it an increasingly vital player on the world stage. This momentum presents new opportunities, as well as challenges, which are expected to be addressed at AntibodyChina 2025.

AntibodyChina 2025 will take place from February 27-28, 2025, in Nanjing, China, and will gather industry leaders, researchers, and innovators to explore the latest developments in antibody drug research and development. With its 8th edition, the summit will focus on critical topics such as:

• Scientific breakthroughs in bispecific antibodies and ADCs
• Overcoming technical bottlenecks in large-scale production
• Innovative collaboration models within the industry

This year, Hzymes is honored to be part of this prestigious event. We will be presenting our one-stop full-process technology empowerment platform at Booth T5, offering a wide range of services and solutions designed to support the development and production of next-generation antibody drugs and ADCs.

Our platform provides comprehensive support across various stages of the process, including:

• Quality Control: Ensuring the highest standards for both raw materials and finished products.

• CMC Process Enzymes: Tailored enzymes to optimize manufacturing processes.

• Excipients: Advanced formulations to enhance the stability and efficacy of therapeutics.

• mRNA Antigen Design: Cutting-edge solutions for mRNA-based therapies.

• Custom Services: Providing bespoke services for specific client needs in antibody drug development.

The summit will highlight the vital role of collaboration and innovation in shaping the future of antibody-based therapeutics. With Hzymes‘ expertise, we are uniquely positioned to support the development of these groundbreaking therapies, offering solutions that address key challenges in both research and commercialization.

We invite you to visit our booth (T5) to learn more about how we can assist in accelerating your projects. Our team of experts will be available to discuss how our cutting-edge technologies can be integrated into your R&D and manufacturing processes. Whether you are facing technical obstacles or looking to optimize production efficiency, we have the tools and knowledge to help you succeed.

The AntibodyDrug and ADC Deep Focus Summit is an ideal platform for connecting with industry leaders, sharing insights, and exploring new collaborations. We look forward to meeting you in Nanjing and discussing how Hzymes can play a role in advancing your antibody drug and ADC initiatives.

Event Details:

• Date: February 27-28, 2025
• Location: Nanjing, China
• Booth: T5 (Hzymes)

For any inquiries or to schedule a meeting, feel free to contact us at info@hzymes.com, we are eager to connect with you and explore how we can contribute to your success.

We hope to see you at AntibodyChina 2025!

About Hzymes:

Hzymes is committed to providing cutting-edge technological solutions and high-quality services to the biopharmaceutical industry. With a focus on enabling the next generation of antibody drugs and ADCs, we specialize in custom enzymatic processes, mRNA antigen design, and other innovative solutions to accelerate the development and commercialization of biologics.